Lyophilized Sterile Vial
Tested: 99.3%
Current Lot: MV-2026-MOTS40-02
High-Purity Lyophilized Peptide
MOTS-c Mitochondrial Peptide
40mg / 5mL Lyophilized • HPLC Purity: 99.3% • Target: ≥ 99.0%
High-concentration MOTS-c 40mg formulation designed for comprehensive preclinical and metabolic protocol evaluation.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula C101H152N28O22S2
Molecular Weight 2174.6 g/mol
CAS Registry # 1627580-64-6
Peptide Sequence / Structure MRWQEMGYIFYPRKLR
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-MOTS40-02 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Purity (RP-HPLC) | 99.3% | RP-HPLC | Conforms |
| Identity (MS) | 2174.6 Da | ESI-MS | Conforms |
| Net Content | 40.2 mg | UV Spectrophotometry | Conforms |
| Endotoxin | < 0.05 EU/mg | LAL Kinetic | Conforms |
Biological Mechanism of Action
Stimulates cellular glucose uptake and skeletal muscle mitochondrial biogenesis through AMPK-dependent pathways.
Research Focus Areas: Mitochondrial Biology Metabolic Regulation Glucose Uptake
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for MOTS-c 40mg.